Monoclonal Antibodies in a blue background with waters triangles on to the left foreground

Waters Biosimilars Online Seminar Series

Achieve therapeutic safety and efficacy to improve patient health and wellness

Join us for a four-part online seminar series to learn how advanced biotherapeutic characterization technologies from Waters can help laboratories achieve the standards of regulatory bodies around the world to produce sufficient analytical and biological evidence of similarity between innovator and biosimilar candidates that will reduce the clinical trial burden for approval.

What You'll Learn:

§  How Waters consumables enable high quality peptide mapping, glycan and charge variant data.

§  A case study of biosimilar mAb characterization at intact, subunit, and peptide level.

§  How to improve assay robustness and reduce the burden associated with migrating methods downstream in the analysis and monitoring of PQAs of biopharmaceuticals.

Each one-hour presentation will begin at
17:00 Greek time

 

Episode 1: Thursday, September 21st
Chromatographic Techniques for the Characterization of CQAs in Biosimilars

Episode 2: Thursday, September 28th
Robust Multi-Level LC-MS Workflows for Biosimilar Comparability Assessment

Episode 3: Thursday, October 5th
Advancing Technology for Better Medicine

Episode 4: Thursday, October 12th
Hear a customer perspective on deploying Waters solutions to enhance biosimilar development

Click below to view the full agenda and register. You have the option to select individual or all presentations.

Newsletter

Sign up to Hellamco's Mailing List and check out our latest news.
HELLAMCO S.A. will process your personal data only for communication and updating purposes, will not distribute them on to third parties and will keep them in the database for 30 days. For more information regarding the processing of personal data and rights, please visit our relative privacy policy.